CHINA SXT PHARMACEUTICALS IN (SXTC)
VGG2161P1403 - Common Stock
| 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | 2019 (2019-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -5.93M | -5.74M | -2.75M | -10.29M | 1.54M | |||
| Depreciation Amortization | 250.00K | 320.00K | 350.00K | 330.00K | 180.00K | |||
| Income Taxes - Deferred | N/A | 330.00K | -190.00K | -100.00K | -10.00K | |||
| Change In Working Capital | 1.42M | 2.46M | -1.61M | 1.95M | -1.54M | |||
| Interest Paid | 10.00K | 0.00 | 10.00K | 290.00K | 0.00 | |||
| Taxes Paid | 0.00 | 20.00K | 0.00 | 10.00K | 50.00K | |||
| Other non cash items | 4.19M | 2.89M | 2.89M | 9.05M | 70.00K | |||
| OPERATING CASH FLOW | -80.00K | 270.00K | -1.32M | 930.00K | 240.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -70.00K | -60.00K | -90.00K | -410.00K | -610.00K | |||
| Other Investing Activity | 60.00K | 20.00K | -5.71M | -5.09M | N/A | |||
| INVESTING CASH FLOW | -10.00K | -50.00K | -5.81M | -5.50M | -610.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 4.00M | 2.32M | -120.00K | 6.72M | 30.00K | |||
| Stock Issued/Repurchased | 2.19M | 3.12M | N/A | N/A | 6.49M | |||
| Other Financing Activity | -3.26M | -3.84M | 12.53M | -3.70M | 2.52M | |||
| FINANCING CASH FLOW | 2.94M | 1.60M | 12.41M | 3.02M | 9.04M | |||
| Exchange Rate Effect | -1.05M | 390.00K | 780.00K | -470.00K | -40.00K | |||
| CHANGE IN CASH | 1.80M | 2.21M | 6.06M | -2.02M | 8.63M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -80.00K | 270.00K | -1.32M | 930.00K | 240.00K | |||
| Capital Expenditure | -70.00K | -60.00K | -90.00K | -410.00K | -610.00K | |||
| FREE CASH FLOW | -150.00K | 210.00K | -1.41M | 520.00K | -370.00K | |||
All data in USD